Shareholders Foundation, Inc.

Bio-Reference Laboratories Inc (NASDAQ:BRLI) Shareholder Alert: Investigation of Takeover by OPKO HEALTH, INC

An investigation on behalf of investors of Bio-Reference Laboratories Inc (NASDAQ:BRLI) in connection with the proposed takeover was announced and NASDAQ:BRLI stockholders should contact the Shareholders Foundation.

 

San Diego, CA -- (SBWIRE) -- 06/17/2015 -- An investigation for investors, who currently hold NASDAQ:BRLI shares o, was announced concerning whether the takeover of Bio-Reference Laboratories. by OPKO HEALTH, INC for a value of approximately $52.58 is unfair to NASDAQ:BRLI stockholders.

Investors who purchased shares of Bio-Reference Laboratories Inc (NASDAQ:BRLI) and currently hold any of those NASDAQ:BRLI shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain officers and directors of Bio-Reference Laboratories Inc breached their fiduciary duties owed to NASDAQ:BRLI investors in connection with the proposed acquisition.

On Jun. 4, 2015, OPKO HEALTH, INC. (NYSE:OPK) and Bio-Reference Laboratories Inc (NASDAQ:BRLI) announced that the companies have signed a merger agreement under which OPKO HEALTH, INC will acquire Bio-Reference Laboratories Inc (NASDAQ:BRLI). Under the terms of the agreement, shareholders of Bio-Reference Laboratories Inc (NASDAQ:BRLI) common stock will receive 2.75 shares of OPKO HEALTH, INC. (NYSE:OPK) common stock for each share of Bio-Reference Laboratories Inc (NASDAQ:BRLI) common stock. Based on a closing price of $19.12per share of OPKO HEALTH, INC. (NYSE:OPK) common stock on June 3, 2015, the transaction is valued at approximately $1.47 billion, or $52.58 per share of Bio-Reference Laboratories Inc (NASDAQ:BRLI) common stock.

However, the investigation concerns whether the offer is unfair to NASDAQ:BRLI stockholders. More specifically, the investigation concerns whether the Bio-Reference Laboratories Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Those who are current investors in Bio-Reference Laboratories Inc (NASDAQ:BRLI) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com